Real-time enrollment status for this brca1/2-associated hereditary breast and ovarian cancer syndrome clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:13 PM UTC
| NCT Number | NCT04494945 |
| Recruiting Status | Recruiting |
| Condition | BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 27,500 participants |
| Active Locations | 2 sites in the US |
| Sponsor | OHSU Knight Cancer Institute |
| Last Updated on CT.gov | January 23, 2026 (Jan 23, 2026) |
As of July 13, 2026: Clinical trial NCT04494945 is currently recruiting participants. This clinical trial study for brca1/2-associated hereditary breast and ovarian cancer syndrome is actively seeking new participants at 2 locations across the United States. The study is sponsored by OHSU Knight Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04494945 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04494945 was last updated Jan 23, 2026 (January 23, 2026). HelloStudys verifies this status automatically.